Navigation Links
Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
Date:6/28/2011

may one day provide a benefit to patients with FRA-positive NSCLC."

Farletuzumab is a monoclonal antibody that binds to and blocks the function of FRA, a cell surface protein on tumor cells that confers a growth advantage to tumorigenic ovarian cells in vitro.  FRA has been demonstrated by several independent studies to be expressed on a variety of cancer types including non-small cell lung adenocarcinoma. Preclinical data support the theory that farletuzumab achieves its pharmacological effect by two mechanisms: first, by the capacity of farletuzumab to block signaling inside cancer cells and, second, by stimulating the patient's immune system to attack and destroy the FRA-positive tumor cells.

Lung cancer is the leading cause of cancer death worldwide. NSCLC represents more than 85% of lung cancer cases, with the majority being diagnosed in advanced stages. Estimates for lung cancer in the United States are predicted to be over 220,000 new cases and 155,000 deaths from the disease annually.(1)  Over 360,000 deaths from lung cancer are expected annually in the European Region. Approximately 15% of patients in these regions with NSCLC will survive five years, reflecting the limited potential of currently available therapies.(2)

Further information on the clinical study can be found at www.clinicaltrials.gov, study number NCT01218516.

About MorphotekMorphotek®, Inc., a subsidiary of Eisai Inc., is a biopharmaceutical company specializing in the development of protein and antibody products through the use of a novel and proprietary gene evolution technology.  The technology has been successfully applied to a broad variety of cell lines and organisms to yield genetically diverse offspring that are suitable for pharmaceutical product development in the areas of antibody therapeutics, protein therapeutics, product manufacturing, drug target discovery, and improved ou
'/>"/>

SOURCE Morphotek, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Morphotek®, Inc. Announces Acquisition of Tumor Targeting Assets From Transmolecular, Inc.
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... TAIPEI , Sept. 1, 2015 ... (GNTbm) held a press conference in Taipei ... developments in its new Vaucarrin™ platform, a targeted drug ... vehicle. This event was part of a ... Gold NanoTech Inc. (GNT), showcasing GNT,s latest ...
(Date:9/1/2015)... Sept. 1, 2015 Sargas Pharmaceutical Adherence ... and Drug Adherence m Health applications along with ... process of non face-to-face monitoring of twenty minutes ... release of our apps, doctors are now well ... with our ONCHIT certified Physician, Pharmacy and Patient ...
(Date:9/1/2015)... -- Agena Bioscience TM today announced the establishment of ... and financial hub from which many biotech and life science ... mainland China . "The Chinese ... with almost sixty MassARRAY ® Systems installed to date. ... us to expand our reach and foster a high degree ...
Breaking Medicine Technology:GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 3GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 4GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 5SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2Agena Bioscience Opens Office in Shanghai, China 2
... 12 Research presented at the American College of ... that an intervention to reduce over-dispensing and waste of ... can result in substantial cost savings. , Medco Health ... of a study that examined the effectiveness and safety ...
... 12 /PRNewswire / -- New research findings ... (SIO) Sixth International Conference in New York show ... complementary and alternative medicine (CAM) using traditional research ... Children,s Hospitals and Clinics of Minnesota (Children,s), presented ...
Cached Medicine Technology:New Research Shows Over-use of Asthma Rescue Inhalers Substantially Reduced Through Pharmacist-initiated Physician Intervention 2New Research Shows Over-use of Asthma Rescue Inhalers Substantially Reduced Through Pharmacist-initiated Physician Intervention 3New Research Shows Promise in Using Traditional Research Methods to Assess Efficacy of Complementary Therapies 2
(Date:9/1/2015)... Zephyrhills, FL (PRWEB) , ... September 01, 2015 , ... ... awareness about this disease that affects more than 233,000 men each year in the ... It is the most common non-skin cancer in America, affecting 1 in 7 men. ...
(Date:9/1/2015)... FL (PRWEB) , ... September 01, 2015 , ... ... and Drug Administration (FDA) for the treatment of androgenic alopecia in adults, announces ... brand new laser therapy cap, while also demonstrating its safety when used at ...
(Date:9/1/2015)... ... 01, 2015 , ... Earth Brands, ( http://www.earthbrands.com ) a ... customer who buys an Earth Brand shoe will be given an opportunity to ... the Future, a nonprofit dedicated to planting more trees. Earth Brands products represent ...
(Date:9/1/2015)... KY (PRWEB) , ... September 01, 2015 , ... ... practice physical therapy company, is pleased to announce their partnership with Apex ... merger allows both groups to continue to provide kind, compassionate, and empathetic care ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... differently. If not managed, stress created from everyday life changes can lead to ... herbs that provide support for coping with stress. Herbal supplement manufacturer MediHerb ...
Breaking Medicine News(10 mins):Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 2Health News:ProRehab Physical Therapy Partnership with Apex Physical Therapy Now Official 3Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 3
... and calls for ... multi-pollutant legislation, NEWARK, N.J., July ... safety, testified today before,Congress about the implications of a recent ... Clean Air Interstate,Rule (also known as CAIR). CAIR would have ...
... PARSIPANNY, N.J., July 29 MD On-Line, ... facilitating electronic,commerce between providers and payers, announced ... on Operating Rules for Information Exchange (CORE(TM)),Clearinghouse ... after MD,On-Line successfully completed Phase I certification ...
... drug-taking athletes from damaging sport by using performance enhancing ... according to a major four-decade review by three of ... , Writing in the August issue of the European-based ... significant advances have been made in the fight against ...
... -- Web-Based Compliance Software Available, ANNAPOLIS, Md., July ... web-based compliance program today called RWSURVEY,available http://www.rwsurvey.com ., ... and create, distribute,and analyze compliance surveys online and includes ... FFIEC NCUA PCI HIPAA Compliance ...
... regular,monitoring of medications by physicians is an effective ... to recent advances in the SMART,Registry, physicians are ... that they never received before., Highmark will ... chronically ill patients fill their prescriptions., "Improving ...
... have contracted a highly resistant strain of the HIV ... the infection. , Research co-authored by the University ... Epidemiology and Clinical Research (NCHECR) shows that the majority ... have had good results from a new combination therapy. ...
Cached Medicine News:Health News:PSEG Supports Quick Congressional Action on Clean Air in Wake of Court's Rescinding of CAIR 2Health News:MD On-Line Achieves CAQH CORE(TM) Certification for Consistent Healthcare Administrative Data Exchange 2Health News:MD On-Line Achieves CAQH CORE(TM) Certification for Consistent Healthcare Administrative Data Exchange 3Health News:Scientists race to stay ahead of the drug-taking and genetic manipulation that threatens sport 2Health News:Scientists race to stay ahead of the drug-taking and genetic manipulation that threatens sport 3Health News:New Web-Based Compliance Program Released by RiskWatch 2Health News:Highmark's SMART(TM) Registry Reports Aid the Chronically Ill 2Health News:Highmark's SMART(TM) Registry Reports Aid the Chronically Ill 3Health News:New therapy for HIV treatment 2
Straight shafts with 0.12 mm teeth and tying platform. Serrated handle with polished finish....
Angled 45 degree shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Heavy curved shafts with 2 x 2 teeth and crisscross serrated 6 mm tying platform. Serrated handle with polished finish....
Straight shafts with 1 x 2 teeth and 6 mm tying platform. Wide serrated handle with polished finish....
Medicine Products: